Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tools to investigate the ubiquitin proteasome system
Yves Leestemaker, Huib Ovaa
Drug Discovery Today Technologies (2017) Vol. 26, pp. 25-31
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Endoplasmic reticulum stress: an arising target for metal-based anticancer agents
Anna King, Justin J. Wilson
Chemical Society Reviews (2020) Vol. 49, Iss. 22, pp. 8113-8136
Closed Access | Times Cited: 155
Control of the inflammasome by the ubiquitin system
Gloria López‐Castejón
FEBS Journal (2019) Vol. 287, Iss. 1, pp. 11-26
Open Access | Times Cited: 132
USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway
Haiqing He, Lu Yi, Bin Zhang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 10, pp. 2417-2429
Open Access | Times Cited: 92
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia R. Tundo, Diego Sbardella, Anna Maria Santoro, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107579-107579
Open Access | Times Cited: 87
Lipid peroxidation in neurodegeneration
Carmen Peña‐Bautista, Máximo Vento, Miguel Baquero, et al.
Clinica Chimica Acta (2019) Vol. 497, pp. 178-188
Closed Access | Times Cited: 84
The Roles of the Ubiquitin–Proteasome System in the Endoplasmic Reticulum Stress Pathway
Junyan Qu, Tingting Zou, Zhenghong Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1526-1526
Open Access | Times Cited: 76
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
Gabriel LaPlante, Wei Zhang
Cancers (2021) Vol. 13, Iss. 12, pp. 3079-3079
Open Access | Times Cited: 58
Non-proteolytic ubiquitylation in cellular signaling and human disease
Yongrong Liao, Izabela Sumara, Evanthia Pangou
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 40
Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy
Ritesh P. Bhole, Payal R. Kute, Rupesh V. Chikhale, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106720-106720
Closed Access | Times Cited: 23
DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells
Yongjun Wang, Dong Han, Tingwen Zhou, et al.
European Heart Journal (2021) Vol. 42, Iss. 30, pp. 2935-2951
Closed Access | Times Cited: 51
c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis
Chimera Lyle, Mostafa Belghasem, Vipul C. Chitalia
Cells (2019) Vol. 8, Iss. 5, pp. 498-498
Open Access | Times Cited: 53
Characterizing disease-associated changes in post-translational modifications by mass spectrometry
Camilla Thygesen, I. Boll, Bente Finsen, et al.
Expert Review of Proteomics (2018) Vol. 15, Iss. 3, pp. 245-258
Closed Access | Times Cited: 52
Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases
Saeideh Momtaz, Zahra Memariani, Fardous F. El‐Senduny, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 34
The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc.
Yan Sun, Jiquan Fan, Bo Wang, et al.
PubMed (2020) Vol. 10, Iss. 1, pp. 148-163
Closed Access | Times Cited: 33
Advances in Proteasome Enhancement by Small Molecules
Dare E. George, Jetze J. Tepe
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1789-1789
Open Access | Times Cited: 27
Insights into the recognition mechanism in the UBR box of UBR4 for its specific substrates
Da Eun Jeong, Hye Seon Lee, Bonsu Ku, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 12
Bimodular architecture of bacterial effector SAP05 that drives ubiquitin-independent targeted protein degradation
Qun Liu, Abbas Maqbool, Federico Gabriel Mirkin, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 12
Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications
Pascal Heitel
Molecules (2023) Vol. 28, Iss. 2, pp. 690-690
Open Access | Times Cited: 11
Orthogonal approaches required to measure proteasome composition and activity in mammalian brain tissue
Fulya Türker, Rahul Bharadwaj, Joel E. Kleinman, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 6, pp. 104811-104811
Open Access | Times Cited: 11
Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
Yang Zhou, Shujing Xu, Nerea López-Carrobles, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 11
Natural products targeting ubiquitination to combat kidney fibrosis
Dong Li, X. Huang, Yao Chen, et al.
Future Journal of Pharmaceutical Sciences (2025) Vol. 11, Iss. 1
Open Access
Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
Xinmin Zhao, Xianghua Wu, Huijie Wang, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 10
Recent Developments in Cell Permeable Deubiquitinating Enzyme Activity-Based Probes
Daniel Conole, Milon Mondal, Jaimeen D. Majmudar, et al.
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 27
Modulatory effect of MG-132 proteasomal inhibition on boar sperm motility during in vitro capacitation
Lenka Hackerová, Barbora Klusackova, Michal Zigo, et al.
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 8
TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression
Yumin Qiu, Peishu Liu, Xiaomin Ma, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1866, Iss. 9, pp. 1412-1420
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top